|
Release date: July 18, 2005 Gilead Sciences and Royalty Pharma Announce $525 Million Agreement with Emory University to Purchase Royalty Interest for Emtricitabine
|
|
||||||||||||
 |
 |
 |
copyright 2001
For more information contact: